Thyroid disease and osteoporosis.
暂无分享,去创建一个
[1] F. Di Stefano,et al. Use of disphosphonates in the treatment of osteoporosis in thyroidectomized patients on levothyroxin replacement therapy. , 1997, Archives of gerontology and geriatrics.
[2] J. Bringer,et al. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. , 1996, The Journal of clinical endocrinology and metabolism.
[3] B. Uzzan,et al. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. , 1996, The Journal of clinical endocrinology and metabolism.
[4] C. Albanese,et al. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre. , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[5] A. Galløe,et al. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. , 1994, European journal of endocrinology.
[6] N. Waugh,et al. Morbidity in patients on l‐thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH , 1992, Clinical endocrinology.
[7] P. D. Bewsher,et al. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. , 1991, The Journal of clinical endocrinology and metabolism.
[8] L. Braverman,et al. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. , 1988, JAMA.
[9] K. Burman,et al. Prevalence of fractures in postmenopausal women with thyroid disease. , 1993, Thyroid : official journal of the American Thyroid Association.